The US Food and Drug Administration (FDA) approved semaglutide (Ozempic, Novo Nordisk) for reducing the risk for worsening kidney disease and cardiovascular death in adults with both type 2 diabetes ...

Ozempic has expanded beyond its original role in diabetes care to include cardiovascular and kidney protection. But with new approvals, real-world insights, and growing competition reshaping its ...

Please provide your email address to receive an email when new articles are posted on . FDA approved semaglutide to lower the risk for worsening kidney disease, kidney failure and CV death in type 2 ...

Millions of Americans have tried GLP-1 medications like Ozempic, Mounjaro and Wegovy, polls show, but pharmacy claims data show that many people stop taking them within less than one year. There are ...

Ozempic ® is indicated as an adjunct to diet, exercise, and standard of care to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or ...